Journal Of Cardiovascular Pharmacology

Journal Title：Journal Of Cardiovascular Pharmacology

Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.

Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.

Journal of Cardiovascular Pharmacology 是一份同行评审的多学科期刊，发表有关心血管药理学基础和临床方面的原创文章和相关评论文章。该杂志鼓励提交心血管药理学/医学的各个方面，包括但不限于：中风、肾脏疾病、脂质紊乱、糖尿病、全身性和肺动脉高压、癌症血管生成、循环的神经和激素控制、败血症、神经退行性疾病血管成分、心脏和血管重塑、心力衰竭、心绞痛、抗凝剂/抗血小板剂、影响血管平滑肌的药物/药剂和心律失常。

适当的主题包括新药开发和评估、药物作用的生理和药理学基础、代谢、药物相互作用和副作用、应用药物以获得对生理或病理状况的新见解、新药和成熟药物的临床结果，以及新颖的方法。重点是最广泛应用的药理学，不仅包括传统方法，还包括开发药物和预防和治疗心血管疾病的新方法。请注意，JCVP 不发表基于混合和不确定化学成分或未知浓度的生物提取物的工作。

Journal Of Cardiovascular Pharmacology创刊于1979年，由LIPPINCOTT WILLIAMS & WILKINS出版商出版，收稿方向涵盖心血管系统 - 医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度约1月，影响因子指数2.598，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。